{"id":252870,"date":"2026-09-17T13:25:44","date_gmt":"2026-09-17T07:55:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=252870"},"modified":"2026-10-08T10:24:24","modified_gmt":"2026-10-08T04:54:24","slug":"why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/","title":{"rendered":"Astrazeneca Pharma India (ASTRAZEN) Share Price Near 52-Week Low as Stock Trades at Rs 5,866"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN)<\/a> share price is trading within 2% of its 52-week low today and stood at Rs 5,866, down 0.89% from the previous close. Market cap was Rs 14,796.38 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Astrazeneca Pharma India Ltd Share Price is trading at Rs 5,866, down 0.89% on the day, and remains close to its 52-week low while the company\u2019s market capitalisation stands at Rs 14,796.38 crore. Astrazeneca Pharma India Share Price Today is drawing attention because the stock opened at Rs 5,918.60, touched a high of Rs 5,918.60 and a low of Rs 5,866, while the latest Univest data confirms the price event but does not establish a company-specific catalyst. Astrazeneca Pharma India Share Price News is therefore centred on price action, valuation and market positioning rather than a verified trigger. In the current Astrazeneca Pharma India Stock News flow, Univest data points to weak momentum, a premium valuation and a sharp distance from key long-term moving averages. Investors tracking Astrazeneca Pharma India Share Price Today should watch whether the stock stabilises near support or extends its one-year low pressure.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Share_Price_Today_Price_Action_Analysis\" title=\"Astrazeneca Pharma India Share Price Today: Price Action Analysis\">Astrazeneca Pharma India Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\" title=\"Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis\">Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Why_Investors_Are_Watching_Astrazeneca_Pharma_India\" title=\"Why Investors Are Watching Astrazeneca Pharma India\">Why Investors Are Watching Astrazeneca Pharma India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#About_Astrazeneca_Pharma_India\" title=\"About Astrazeneca Pharma India\">About Astrazeneca Pharma India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Track_Astrazeneca_Pharma_India_Share_Price_on_Univest\" title=\"Track Astrazeneca Pharma India Share Price on Univest\">Track Astrazeneca Pharma India Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Why_is_Astrazeneca_Pharma_India_Share_Price_falling_today\" title=\"Why is Astrazeneca Pharma India Share Price falling today?\">Why is Astrazeneca Pharma India Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_is_Astrazeneca_Pharma_India_Share_Price_today\" title=\"What is Astrazeneca Pharma India Share Price today?\">What is Astrazeneca Pharma India Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Is_Astrazeneca_Pharma_India_near_its_52-week_low\" title=\"Is Astrazeneca Pharma India near its 52-week low?\">Is Astrazeneca Pharma India near its 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#How_does_Astrazeneca_Pharma_India_compare_with_its_sector_benchmark\" title=\"How does Astrazeneca Pharma India compare with its sector benchmark?\">How does Astrazeneca Pharma India compare with its sector benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Is_Astrazeneca_Pharma_India_expensive_on_valuation\" title=\"Is Astrazeneca Pharma India expensive on valuation?\">Is Astrazeneca Pharma India expensive on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#How_does_Astrazeneca_Pharma_India_compare_with_peers\" title=\"How does Astrazeneca Pharma India compare with peers?\">How does Astrazeneca Pharma India compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_should_investors_watch_next_in_Astrazeneca_Pharma_India_Share_Price\" title=\"What should investors watch next in Astrazeneca Pharma India Share Price?\">What should investors watch next in Astrazeneca Pharma India Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_do_ROE_and_ROCE_show_for_Astrazeneca_Pharma_India\" title=\"What do ROE and ROCE show for Astrazeneca Pharma India?\">What do ROE and ROCE show for Astrazeneca Pharma India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Should_investors_track_Astrazeneca_Pharma_India_Share_Price_on_Univest\" title=\"Should investors track Astrazeneca Pharma India Share Price on Univest?\">Should investors track Astrazeneca Pharma India Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Astrazeneca Pharma India Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,866<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,918.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -52.55 (-0.89%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,918.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,918.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,866<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,796.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 5,866 versus the previous close of Rs 5,918.55, a fall of 0.89%. The stock opened at Rs 5,918.6, reached a high of Rs 5,918.6, touched a low of Rs 5,866.<\/p>\n<p>Astrazeneca Pharma India Share Price Today shows a modest intraday decline from the previous close of Rs 5,918.55 to Rs 5,866, a fall of Rs 52.55 or 0.89%. The stock opened at Rs 5,918.60, matched the day\u2019s high at Rs 5,918.60, and then moved down to Rs 5,866, which also stands as the day\u2019s low. That price path indicates immediate selling pressure after the open, with Astrazeneca Pharma India Share Price holding close to the lower end of the day\u2019s range. With market capitalisation at Rs 14,796.38 crore, Astrazeneca Pharma India Share Price News remains relevant for traders who monitor price action, support and one-year low levels. The current move keeps Astrazeneca Pharma India Share Price within the 52-week low discussion, and the next question is whether the stock can base near this zone or stay under pressure on Share Market Today.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,796.38 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">87.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.36x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 361.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.61%<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P\/E 87.23x, P\/B 16.36x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 14,796.38 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 87.23x, P\/B at 16.36x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.61%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 27.91x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">87.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.91x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 708.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.36x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,796.38 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 828.13 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 87.23x, which is above the benchmark median of 27.91x, a difference of +212.54%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.48%, a difference of +100.52%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.28%, a difference of +135.24%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Marksans Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MARKSANS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14,698.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Concord Biotech Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CONCORDBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14,306.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/jublpharma\/jubilant-pharmova-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Jubilant Pharmova Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">JUBLPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,737.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.69<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Natco Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NATCOPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,158.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alembic Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APLLTD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,391.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.74<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 87.23x compared with the displayed peer median of 28.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 13.54% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 17.16%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 14,796.38 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Astrazeneca_Pharma_India\"><\/span><strong>Why Investors Are Watching Astrazeneca Pharma India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Astrazeneca Pharma India Share Price is trading near its 52-week low, keeping price action in focus.<\/li>\n<li>RSI at 17.75 shows weak momentum and deep oversold conditions in Astrazeneca Pharma India Share Price Today.<\/li>\n<li>The stock trades below the 50-day and 200-day moving averages, which keeps the trend under pressure.<\/li>\n<li>Valuation remains elevated, with Astrazeneca Pharma India Fundamental Analysis showing a high P\/E and P\/B.<\/li>\n<li>ROE of 23.02% and ROCE of 31.24% show strong return metrics despite the weak share price.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Astrazeneca_Pharma_India\"><\/span><strong>About Astrazeneca Pharma India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astrazeneca Pharma India Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. Astrazeneca Pharma India Share Price reflects the market\u2019s view of a company whose reported financial ratios show strong profitability and premium valuation. The latest quarter revenue of Rs 682.79 crore for Jun 2026 gives a recent operating reference point for Astrazeneca Pharma India Company News and Astrazeneca Pharma India Stock Performance. The company\u2019s market cap of Rs 14,796.38 crore places it in the mid-to-large bracket within its industry set. Investors often track Astrazeneca Pharma India Share Price Today alongside company financials, earnings quality, book value and return ratios because the stock trades at a notable premium to the industry norm. In Univest coverage, Astrazeneca Pharma India Stock News is best understood through a combination of price behaviour, valuation and sector-relative profitability.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Astrazeneca_Pharma_India_Share_Price_on_Univest\"><\/span><strong>Track Astrazeneca Pharma India Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n<p>Track Astrazeneca Pharma India Share Price on Univest to follow live price updates, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. Univest helps readers monitor Astrazeneca Pharma India Share Price Today with a clear view of stock analysis, sector context and company financials.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Astrazeneca_Pharma_India_Share_Price_falling_today\"><\/span><strong>Why is Astrazeneca Pharma India Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price is down 0.89% to Rs 5,866. Univest data confirms weak price action near a 52-week low, but it does not establish a company-specific catalyst for the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Astrazeneca_Pharma_India_Share_Price_today\"><\/span><strong>What is Astrazeneca Pharma India Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price today is Rs 5,866, compared with the previous close of Rs 5,918.55. The stock opened at Rs 5,918.60 and moved lower during the morning session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Astrazeneca_Pharma_India_near_its_52-week_low\"><\/span><strong>Is Astrazeneca Pharma India near its 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Astrazeneca Pharma India Share Price is trading close to its 52-week low, which is why it is drawing attention as a stocks in news name on Stock Market Today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astrazeneca_Pharma_India_compare_with_its_sector_benchmark\"><\/span><strong>How does Astrazeneca Pharma India compare with its sector benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price trades at a P\/E of 87.23 versus the industry median of 27.91 and an average of 40.94. Its ROE and ROCE are both above the benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Astrazeneca_Pharma_India_expensive_on_valuation\"><\/span><strong>Is Astrazeneca Pharma India expensive on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price looks higher-valued versus the healthcare benchmark on both P\/E and P\/B. However, the company\u2019s higher ROE and ROCE show strong return generation against that valuation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astrazeneca_Pharma_India_compare_with_peers\"><\/span><strong>How does Astrazeneca Pharma India compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price has a market cap close to Marksans Pharma and Concord Biotech, but its P\/B is much higher than most listed peers in the comparison set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_watch_next_in_Astrazeneca_Pharma_India_Share_Price\"><\/span><strong>What should investors watch next in Astrazeneca Pharma India Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should watch whether Astrazeneca Pharma India Share Price stays near support, remains below the 50-day and 200-day moving averages, and holds its current trend around the yearly low zone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Astrazeneca_Pharma_India\"><\/span><strong>What do ROE and ROCE show for Astrazeneca Pharma India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price is backed by ROE of 23.02% and ROCE of 31.24%. Those numbers indicate strong capital efficiency even though the stock price is weak. ROE stands at 23.02%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Astrazeneca_Pharma_India_Share_Price_on_Univest\"><\/span><strong>Should investors track Astrazeneca Pharma India Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Univest tracks Astrazeneca Pharma India Share Price Today with live updates, technical indicators, valuation ratios and shareholding pattern so investors can monitor the stock\u2019s near-52-week-low setup. The stock moved -0.89% during the session.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrazeneca Pharma India Ltd. Share Price trades near its 52-week low at Rs 5,866, marking a 0.89% decline today. Market cap stands at Rs 14,796.38 crore.<\/p>\n","protected":false},"author":38,"featured_media":293858,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-252870","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["293858"],"rank_math_title":["Astrazeneca Pharma India Share Price Near Low, RSI Weak"],"rank_math_description":["Astrazeneca Pharma India Share Price is near its 52-week low at Rs 5,866, down 0.89%. Check price action, RSI, valuation, peers and sector context."],"rank_math_focus_keyword":["Astrazeneca Pharma India Ltd Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/astrazeneca-pharma-india-astrazen-share-price-near-52-week-low-as-stock-trades-1.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=252870"}],"version-history":[{"count":6,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252870\/revisions"}],"predecessor-version":[{"id":293862,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252870\/revisions\/293862"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/293858"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=252870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=252870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=252870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}